HIV 'wonder drug' seeing dropouts due to side effects
Dolutegravir
(DTG), the wonder drug recently added to the basket of medicines to treat HIV
in the country, is causing weight gain, diabetes, ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.